This dataset consists of 174 WSI ovary whole slide images (WSI): 158 malignant and 16 benign. Eight of the most common, histological definable tumour types were annotated: high grade serous carcinoma (HGSC), low grade serous carcinoma (LGSC), clear cell carcinoma (CC), endometrioid adenocarcinoma (EN), metastastic serous carcinoma (MS), metastatic other (MO), serous borderline tumor (SB) and mucinous borderline tumor (MB). Also normal ovarian tissue were annotated. 2402 separate annotations were made. For the benign structures only the epithelial structures, stroma and support tissue were annotated.
Keywords: Pathology, Ovary, Cancer, Whole slide imaging, Annotated.
Sample images
Sample images with reduced image quality. Please click to preview.
Dataset information
| Short name | DROV |
|---|---|
| Origin | Clinical |
| Cite as |
Karin Lindman, Jerónimo F. Rose, Martin Lindvall, and Caroline Bivik Stadler
(2019)
Ovary data from the Visual Sweden project DROID
doi:10.23698/aida/drov [BibTeX format]
|
| Field | Pathology |
| Organ |
Ovary |
| Age span | 17-86 years |
| Title | Ovary data from the Visual Sweden project DROID |
| Author |
Karin Lindman
Jerónimo F. Rose Martin Lindvall Caroline Bivik Stadler |
| Year | 2019 |
| DOI | doi:10.23698/aida/drov |
| Status | Completed |
| Version | 1.1.0 |
| Scans | 193 |
| Annotations | 2402 |
| Size | 108.59GB |
| Resolution | 20X single plane |
| Modality |
SM
|
| Scanner |
Scanscope AT (Aperio, US) NanoZoomer XR (Hamamatsu, Japan) NanoZoomer XRL (Hamamatsu, Japan) |
| Stain | H&E (hematoxylin and eosin) |
| Phase | |
| References | |
| Copyright | Copyright 2019 Linköping University, Claes Lundström |
| Access |
Available under the following licenses, described in the License section below.
Controlled access
AIDA BY license
|
Annotation
One physician was responsible for the manual annotations controlled by a second pathologist.
Eight of the most common, histological definable tumour types were annotated: high grade serous carcinoma (HGSC), low grade serous carcinoma (LGSC), clear cell carcinoma (CC), endometrioid adenocarcinoma (EN), metastastic serous carcinoma (MS), metastatic other (MO), serous borderline tumor (SB) and mucinous borderline tumor (MB). Also normal ovarian tissue was annotated. In total 2402 separate annotations were made. For the benign structures only the epithelial structures, stroma and support tissue were annotated.
File formats
Pixel position scaling
Coordinates given are relative to the image width. To get the correct pixel position, X coordinates (and Y coordinates!) should therefore be multiplied with the image width.
License
Controlled access
Free for use in legal and ethical medical diagnostics research.
To request access to the dataset, use the Apply for access button below.
Note that the recipient researcher must hold at least a PhD degree in a
relevant field and that the applicant should be an authorized signatory who can
legally enter into data sharing agreements on the behalf of the institution.
Help with applying for controlled access.
AIDA BY license
Copyright 2019 Linköping University, Claes Lundström
Permission to use, copy, modify, and/or distribute this data within Analytic Imaging Diagnostics Arena (AIDA) for the purpose of medical diagnostics research with or without fee is hereby granted, provided that the above copyright notice and this permission notice appear in all copies, and that publications resulting from the use of this data cite the following works:
Karin Lindman, Jerónimo F. Rose, Martin Lindvall, and Caroline Bivik Stadler (2019) Ovary data from the Visual Sweden project DROID doi:10.23698/aida/drov.
THE DATA IS PROVIDED “AS IS” AND THE AUTHOR DISCLAIMS ALL WARRANTIES WITH REGARD TO THIS DATA INCLUDING ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS. IN NO EVENT SHALL THE AUTHOR BE LIABLE FOR ANY SPECIAL, DIRECT, INDIRECT, OR CONSEQUENTIAL DAMAGES OR ANY DAMAGES WHATSOEVER RESULTING FROM LOSS OF USE, DATA OR PROFITS, WHETHER IN AN ACTION OF CONTRACT, NEGLIGENCE OR OTHER TORTIOUS ACTION, ARISING OUT OF OR IN CONNECTION WITH THE USE OR CHARACTERISTICS OF THIS DATA.